Success story - Artelo Bio lists shares on the Nasdaq
Artelo focuses on accelerating the development and commercialisation of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. Their aim is ultimately the delivery of new medicines to help with a wide range of diseases.
Advisers: Maxim Group LLC acted as sole book-running manager for the offering.
Renatus Comment: Artelo was founded by Peter O'Brien and Greg Gorgas just three years ago. This share offering marks another step in the company's growth journey which looks set to kick on from here.
Source: Global News Wire